Literature DB >> 12381958

Chronic hypercalcemia as the presenting feature of tuberculous peritonitis in a hemodialysis patient.

Chien-Te Lee1, Kuei-Hung Hung, Chih-Hsiung Lee, Hock-Liew Eng, Jin-Bor Chen.   

Abstract

Hypercalcemia is a common electrolyte disturbance in chronic dialysis patients. Although most causes are easily identified, some are obscure. Tuberculosis, a granulomatous disease associated with hypercalcemia, can appear at anytime while the infection is active. Dialysis-associated tuberculosis is characterized by a higher risk than that in the general population, with a greater chance of extrapulmonary involvement and a high mortality rate. If the presentation of tuberculosis is atypical and its manifestation nonspecific, diagnosis can be delayed, leading to poor patient outcome. Herein, we report a case of tuberculous peritonitis in a hemodialysis patient. Asymptomatic hypercalcemia was noted 8 months before ascites became detectable. Nevertheless, the patient responded well to antituberculous therapy. We conclude that hypercalcemia can be an early sign of tuberculous peritonitis in the absence of other signs and symptoms. Remaining aware of the possibility of tuberculosis and testing for it, physicians can identify tuberculous infection earlier and initiate appropriate therapy in a timely manner. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12381958     DOI: 10.1159/000065264

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  2 in total

Review 1.  Endocrine and Metabolic Aspects of Tuberculosis.

Authors:  Christopher Vinnard; Emily A Blumberg
Journal:  Microbiol Spectr       Date:  2017-01

2.  Extra-pulmonary tuberculosis infection in the dialysis patients with end stage renal diseases: case reports and literature review.

Authors:  Wen-fang Yang; Fei Han; Xiao-hui Zhang; Ping Zhang; Jiang-hua Chen
Journal:  J Zhejiang Univ Sci B       Date:  2013-01       Impact factor: 3.066

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.